Atovaquone
Atovaquone 750mg/5ml
Antiparasitic - Pneumocystis
1 ) Treatment of mild-to-moderate PCP in adults and adolescents aged 13 years and older who cannot tolerate TMP-SMX2 ) Limitations of Use ( 13 ): Treatment of severe PCP (alveolar arterial oxygen diffusion gradient [(A-a)DO 2 ] >45 mm Hg) with atovaquone oral suspension has not been studiedThe efficacy of atovaquone oral suspension in subjects who are failing therapy with TMP-SMX has also not been studied
